As an ever greater number of companies seek to provide vaccines and enter the lucrative race of who will provide what and who will be awarded plush government contracts, we can see that not all Big Pharma stocks are shining, pricewise.
Time will tell but if hindsight can teach us something, it is that whoever invested in this rather obscure and not well known company called 'Sorrento Therapeutics", the investment would have been more rewarding than a comparable investment into GlaxoSmithKline plc.
Words of wisdom: if you have extra cash lying around, do a careful and thorough analysis first. That is true, at all time, and even more so now, in this Covid-branded and forever altered world.
Francois Normandeau Institutional Research Director for ADX-BRIEFING
P.S. Live Stream on TradingView on Friday, January 1, 2021, at 6 am NY time, open to all. See you there.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.